Mironid® Limited
United Kingdom
- North Lanarkshire
- 14/09/2023
- Series A
- Undisclosed Amount
Mironid Limited is an innovative new drug discovery company that develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. This allows us to access multiple therapeutic areas for exploitation. Our current drug discovery pipeline is aimed at developing novel treatments for degenerative kidney diseases, chronic inflammatory diseases and cancer.
- Industry Pharmaceutical Manufacturing
- Website https://www.mironid.com/
- LinkedIn https://www.linkedin.com/company/mironid-limited/
Related People
Neil WilkieFounder
United Kingdom -
Greater Glasgow Area
Experienced C-level Pharmaceutical Executive with extensive experience of technical drug discovery combined with investment and company building experience. Graduate of MIT's Global Entrepreneurship Development Program.
Dynamic and versatile with 25+ years’ experience of delivering value from investments in the pharmaceutical and biotechnology sectors. A high-energy enthusiastic leader with a strong strategic aptitude and relationship-building style who leads with the end-goal in mind, utilising established senior-level networks, a proven history of leadership and a track record of channeling strategic vision into defined plans of action.
Specialties: Pharmaceutical Drug Development, Company Creation & Building, Business and Investment Analysis, Corporate Programme Management.
Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)